Nykode Therapeutics - Grant of share options
Nykode Therapeutics ASA (NYKD) · publisert 2026-01-30 21:44 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Barbara Krebs-Pohl | – | other | 300 000 | 0 NOK | 2026-01-30 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| John Beadle | – | other | 150 000 | 0 NOK | 2026-01-30 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Susanne Stuffers | – | other | 150 000 | 0 NOK | 2026-01-30 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
Vedlegg
- Attachment Options 300126.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, January 30, 2026 - Reference is made to the Extraordinary General Meeting (EGM) in Nykode Therapeutics ASA held on January 21, 2026, where the grant of share options to certain members of the Board was approved. A total of 600,000 share options with a strike price of NOK 7.00 per share have been granted in accordance with the terms set out in the minutes from the EGM.
Please see further details in attached document